ES8800664A1 - Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos - Google Patents

Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos

Info

Publication number
ES8800664A1
ES8800664A1 ES552870A ES552870A ES8800664A1 ES 8800664 A1 ES8800664 A1 ES 8800664A1 ES 552870 A ES552870 A ES 552870A ES 552870 A ES552870 A ES 552870A ES 8800664 A1 ES8800664 A1 ES 8800664A1
Authority
ES
Spain
Prior art keywords
compounds
formula
sulfonylaminoethyl
preparation
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552870A
Other languages
English (en)
Other versions
ES552870A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853508692 external-priority patent/DE3508692A1/de
Priority claimed from DE19853541854 external-priority patent/DE3541854A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES552870A0 publication Critical patent/ES552870A0/es
Publication of ES8800664A1 publication Critical patent/ES8800664A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS SULFONILAMINOETILICOS, DE FORMULA (I), Y DE SUS SALES CON BASES. COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN DERIVADO DE ACIDO FENILSULFONICO DE FORMULA R1-SO2X, EN UN DISOLVENTE INERTE, EN PRESENCIA DE UN AGENTE FIJADOR DE ACIDOS, A UNA TEMPERATURA COMPRENDIDA ENTRE 0JC Y 50JC, PARA OBTENER UN COMPUESTO DE FORMULA (I), EN LAS QUE X REPRESENTA UN GRUPO LABIL NUCLEOFILO, Y R1, R2, A, B Y E PUEDEN SER VARIOS TIPOS DE RADICALES. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS EFECTOS ANTITROMBOTICOS E INHIBIDORES SOBRE LA AGREGACION DE PLAQUETAS.
ES552870A 1985-03-12 1986-03-11 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos Expired ES8800664A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853508692 DE3508692A1 (de) 1985-03-12 1985-03-12 3-(4-(2-benzolsulfonylamino-aethyl)-benzoyl)propionsaeure, diese verbindung enthaltende arzneimittel und verfahren zu ihrer herstellung
DE19853541854 DE3541854A1 (de) 1985-11-27 1985-11-27 Neue sulfonylaminoaethylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES552870A0 ES552870A0 (es) 1987-11-16
ES8800664A1 true ES8800664A1 (es) 1987-11-16

Family

ID=25830225

Family Applications (5)

Application Number Title Priority Date Filing Date
ES552870A Expired ES8800664A1 (es) 1985-03-12 1986-03-11 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557210A Expired ES8705378A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557211A Expired ES8705855A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557213A Expired ES8705857A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557212A Expired ES8705856A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES557210A Expired ES8705378A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557211A Expired ES8705855A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557213A Expired ES8705857A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES557212A Expired ES8705856A1 (es) 1985-03-12 1986-11-20 Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos

Country Status (11)

Country Link
EP (1) EP0194548A3 (es)
AU (1) AU5461286A (es)
DK (1) DK110886A (es)
ES (5) ES8800664A1 (es)
FI (1) FI860971A7 (es)
GR (1) GR860654B (es)
HU (1) HU195770B (es)
IL (1) IL78079A0 (es)
NO (1) NO860918L (es)
PH (1) PH22480A (es)
PT (1) PT82169B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0265818B1 (de) * 1986-10-27 1994-09-28 Chemische Fabrik Stockhausen GmbH Verfahren zur Herstellung von N,N-disubstituierten Beta-Aminopropionsäuren und ihre Verwendung zur Hydrophobierung von Leder und Pelzen
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
US4752613A (en) * 1987-08-03 1988-06-21 E. R. Squibb & Sons, Inc. Sulphonamidothienylcarboxylic acid compounds
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
DE3819052A1 (de) * 1988-06-04 1989-12-07 Basf Ag Neue sulfonamid-derivate, ihre herstellung und verwendung
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US5106991A (en) * 1989-06-02 1992-04-21 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
US4975452A (en) * 1989-06-02 1990-12-04 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5280034A (en) * 1991-08-23 1994-01-18 E. R. Squibb & Sons, Inc. Bis-heterocyclic prostaglandin analogs
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
US5739132A (en) * 1992-07-02 1998-04-14 Tanabe Seiyaku Co., Ltd. Pyridazinone derivatives and processes for preparing the same
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5965732A (en) * 1993-08-30 1999-10-12 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co History of pyridazinone and processes for their preparation
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
EP0904077A4 (en) 1996-02-20 1999-12-22 Bristol Myers Squibb Co PROCESSES FOR THE PRODUCTION OF BIPHENYL ISOXAZOLE SULFAMIDES
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
AP9901643A0 (en) 1997-04-28 1999-10-02 Texas Biotechnology Corp Sulfonamides for treatment of endothelin-mediated disorders.
IL144708A0 (en) 1999-03-19 2002-06-30 Bristol Myers Squibb Co Methods for the preparation of biphenyl isoxazole sulfonamide derivatives
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
UA95644C2 (ru) 2006-07-25 2011-08-25 Сефалон, Инк. Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel

Also Published As

Publication number Publication date
DK110886D0 (da) 1986-03-11
FI860971A0 (fi) 1986-03-10
GR860654B (en) 1986-07-11
ES557211A0 (es) 1987-05-16
ES557212A0 (es) 1987-05-16
IL78079A0 (en) 1986-07-31
NO860918L (no) 1986-09-15
PT82169A (de) 1986-04-01
PT82169B (de) 1988-01-04
HUT42062A (en) 1987-06-29
ES557213A0 (es) 1987-05-16
EP0194548A3 (de) 1988-08-17
FI860971A7 (fi) 1986-09-13
ES552870A0 (es) 1987-11-16
ES8705378A1 (es) 1987-05-01
EP0194548A2 (de) 1986-09-17
HU195770B (en) 1988-07-28
ES8705857A1 (es) 1987-05-16
ES8705856A1 (es) 1987-05-16
AU5461286A (en) 1986-10-16
ES557210A0 (es) 1987-05-01
ES8705855A1 (es) 1987-05-16
DK110886A (da) 1986-09-13
PH22480A (en) 1988-09-12

Similar Documents

Publication Publication Date Title
ES8800664A1 (es) Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES8801276A1 (es) Procedimiento para preparar nuevos derivados imidazo
ES8801642A1 (es) Un procedimiento para la preparacion de l,2,4-triazoles
SE7703263L (sv) Forfarande for framstellning av nya acetohydroxaminsyror
ES8303918A1 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8707239A1 (es) Procedimiento para preparar nuevos derivados imidazo.
ES8601992A1 (es) Procedimiento para preparar 2-fenil-imidazoles
ES8703437A1 (es) Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados
ES8308841A1 (es) "un procedimiento para la preparacion de derivados tetrassubstitudos del benceno".
ES8702343A1 (es) Un procedimiento para la produccion de un derivado de diami-das de n-acilaminoacidos
ES8701145A1 (es) Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.
ES8304538A1 (es) "procedimiento para la preparacion de nuevas fenilalcohilaminas".
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8504127A1 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
ES8704503A1 (es) Procedimiento para preparar sales de ciclimonio
ES8609323A1 (es) Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas.
ES8609246A1 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES8601209A1 (es) Procedimiento para preparar derivados de 5h-(1)-benzopirano-(2,3-d)pirimidina
ES8604164A1 (es) Procedimiento para preparar nuevos bencimidazoles
ES8304977A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
ES8607279A1 (es) Un procedimiento para preparar una quinolona
ES8702390A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina